Jazz Pharma inks deal with Saniona to develop SAN2355

Ireland-headquartered Jazz Pharmaceuticals (Nasdaq JAZZ) and Denmark’s Saniona (Nasdaq OMX: SANION) have entered into a global license agreement for Jazz to obtain exclusive worldwide rights to develop SAN2355, a highly differentiated, subtype-selective Kv7.2/Kv7.3 activator.

Saniona’s shares leapt as much as 58% to 12.92 kroner on the news of the potentially over billion-dollar deal.

The compound is in pre-clinical development for epilepsy and other potential indications, designed to overcome the limitations of non-selective Kv7-targeting compounds. Jazz will lead and fund further development, regulatory submissions, and global commercialization activities.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week.

Related Posts

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

NEW DELHI:  In a move to bolster pharmaceutical manufacturing standards across India, the Central Drugs Standard Control Organisation (CDSCO) has instructed state drug regulators to ensure rigorous compliance with the updated…

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

Chennai:  Indian Institute of Technology Madras (IIT Madras) researchers have developed and patented a cost-effective, user-friendly, and minimally invasive glucose monitoring device for diabetes patients. They have reimagined the device…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

Rising Tide of Spurious Drugs in India: Recent Cases Highlight Nationwide Crackdown Amid Quality Concerns

Rising Tide of Spurious Drugs in India: Recent Cases Highlight Nationwide Crackdown Amid Quality Concerns

AGTF arrests man accused of smuggling drugs into USA by concealing them in granite lamps

AGTF arrests man accused of smuggling drugs into USA by concealing them in granite lamps

DCA raids expose steroid trade in Hyd gyms

DCA raids expose steroid trade in Hyd gyms

SPARSH Hospitals is poised to ‘Touch’ with Compassion Lives of Cancer Patients

SPARSH Hospitals is poised to ‘Touch’ with Compassion Lives of Cancer Patients